Bank of America
CAMP icon

Bank of America’s CAMP4 Therapeutics CAMP Stock Holding History

Bank of America’s Portfolio CAMP Stock Details CAMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$138K Buy
31,196
+31,174
+141,700% +$148K ﹤0.01% 5464
2025
Q4 		$135 Sell
22
-261
-92% -$1.11K ﹤0.01% 6769
2025
Q3 		$849 Sell
283
-369
-57% -$683 ﹤0.01% 7513
2025
Q2 		$946 Sell
652
-2,612
-80% -$5.2K ﹤0.01% 7543
2025
Q1 		$13.1K Sell
3,264
-13,195
-80% -$63.8K ﹤0.01% 7065
2024
Q4 		$85.9K Buy
+16,459
New +$135K ﹤0.01% 6457

Other funds holding CAMP

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Bank of America's CAMP Position: Q1 2026 in Review

Bank of America increased its CAMP4 Therapeutics (CAMP) stake by 141,700% in Q1 2026, buying an estimated $148K and bringing the position to 31,196 shares worth $138K. The position accounts for ﹤0.01% of the portfolio, ranked #5464.

Bank of America first reported a position in CAMP in Q4 2024 and has held it in 6 quarters since. 46 funds tracked by Wall St. Rank hold CAMP as of Q1 2026.

  • Bank of America held 31,196 shares of CAMP4 Therapeutics worth $138K as of Q1 2026.
  • Bank of America bought 31,174 CAMP4 Therapeutics shares in Q1 2026, an estimated $148K.
  • CAMP4 Therapeutics made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #5464 holding.
  • Bank of America first reported a position in CAMP4 Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • 46 funds tracked by Wall St. Rank held CAMP4 Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.